Skip to main content
SpringerLink
Log in

Effective Health Screening and Prompt Vaccination to Counter the Spread of COVID-19 and Minimize Its Adverse Effects

  • Chapter
  • First Online:
System Design for Epidemics Using Machine Learning and Deep Learning

Part of the book series: Signals and Communication Technology ((SCT))

  • 177 Accesses

Abstract

Precautionary measures are the best conceivable ways to impede the spreading of COVID-19 disease. Initial stage detection, proper analysis, suitable confinement, effective therapy and prompt vaccination are the key consideration to inhibit expedite transmission. Precautions are primarily concentrated on effective health screening, efficient treatment, and vaccination on time for each and every individual. Before the invention of COVID-19 vaccine, proper health checking or explorations are of predominant concern from therapeutic viewpoint as avoidance is superior than healing. At present scenario, impressive health screening through RT-PCR test, rapid antigen test, etc. is very imperative to identify Corona-positive cases in early stages even there is no disorders or symptoms of COVID-19 infection. Faster vaccination of most of the people, irrespective of cast, religion, and economic conditions, is indispensable to prohibit the transportation of such growing disorder and minimize its adverse effects. Recent literature reveals that most of the vaccines are safe and effective against coronavirus. A potent and competent vaccine lessens mild to moderate and serious conditions of COVID-19 patients regardless of comorbidities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. S. Bag, S. Sikdar, K. Ganguly, S. Banerjee, P. Lahiri, Effective health screening to prevent infection and control the spreading of COVID-19. J. Phys. Conf. Ser. 1797(1), 012040 (2021)

    Article  Google Scholar 

  2. H. Zhu, L. Wei, P. Niu, The novel coronavirus outbreak in Wuhan, China. Glob. Health Res. Policy 5, 6 (2020)

    Article  Google Scholar 

  3. A. Sharma, S. Tiwari, M.K. Deb, J.L. Marty, Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies. Int. J. Antimicrob. Agents 56(2), 106054 (2020)

    Article  Google Scholar 

  4. C.-C. Lai, T.-P. Shih, W.-C. Ko, H.-J. Tang, P.-R. Hsuehe, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents 55(3), 105924 (2020)

    Article  Google Scholar 

  5. Y.-C. Wu, C.-S. Chen, Y.-J. Chan, The outbreak of COVID-19: An overview. J. Chin. Med. Assoc. 83(3), 217–220 (2020)

    Article  Google Scholar 

  6. D. Wu, T. Wu, Q. Liu, Z. Yang, The SARS-CoV-2 outbreak: What we know. Int. J. Infect. Dis. 94, 44–48 (2020)

    Article  Google Scholar 

  7. W. Guan, Z. Ni, Y. Hu, W. Liang, C. Ou, J. He, L. Liu, H. Shan, C. Lei, D.S.C. Hui, B. Du, L. Li, G. Zeng, K.Y. Yuen, R. Chen, C. Tang, T. Wang, P. Chen, J. Xiang, S. Li, J.-l. Wang, Z. Liang, Y. Peng, L. Wei, Y. Liu, Y.-h. Hu, P. Peng, J.-m. Wang, J. Liu, Z. Chen, G. Li, Z. Zheng, S. Qiu, J. Luo, C. Ye, S. Zhu, N. Zhong, Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020, 1708–1720 (2020)

    Article  Google Scholar 

  8. S. Zaim, J.H. Chong, V. Sankaranarayanan, A. Harky, COVID-19 and multiorgan response. Curr. Probl. Cardiol. 45(8), 100618 (2020)

    Article  Google Scholar 

  9. S. Mandal, T. Bhatnagar, N. Arinaminpathy, A. Agarwal, A. Chowdhury, M. Murhekar, R.R. Gangakhedkar, S. Sarkar, Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach. Indian J. Med. Res. 151(2 & 3), 190–199 (2020)

    Google Scholar 

  10. M. Jayaweera, H. Perera, B. Gunawardana, J. Manatungea, Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ. Res. 188, 109819 (2020)

    Article  Google Scholar 

  11. S. Sanche, Y.T. Lin, C. Xu, E. Romero-Severson, N. Hengartner, R. Ke, High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg. Infect. Dis. 26, 1470–1477 (2020)

    Article  Google Scholar 

  12. W.E. Wei, Z. Li, C.J. Chiew, S.E. Yong, M.P. Toh, V.J. Lee, Singapore presymptomatic transmission of SARS-CoV-2. MMWR Morb. Mortal. Wkly Rep. 69, 411–415 (2020)

    Article  Google Scholar 

  13. J. Chen, Pathogenicity and transmissibility of 2019-nCoV – a quick overview and comparison with other emerging viruses. Microbes Infect. 22, 69–71 (2020)

    Article  Google Scholar 

  14. R. Guner, İ. Hasanoğlu, F. Aktas, COVID-19: prevention and control measures in community. Turk. J. Med. Sci. 50(SI-1), 571–577 (2020)

    Article  Google Scholar 

  15. M. Lotfi, M.R. Hamblin, N. Rezaei, COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin. Chim. Acta 508, 254–266 (2020)

    Article  Google Scholar 

  16. R. Keni, A. Alexander, P.G. Nayak, J. Mudgal, K. Nandakumar, COVID-19: emergence, spread, possible treatments, and global burden. Front. Public Health 8, 216 (2020)

    Article  Google Scholar 

  17. F. Krammer, SARS-CoV-2 vaccines in development. Nature 586, 516–527 (2020)

    Article  Google Scholar 

  18. J.P. Moore, P.A. Offit, SARS-CoV-2 vaccines and the growing threat of viral variants. JAMA 325(9), 821–822 (2021)

    Article  Google Scholar 

  19. J.M.G. Wilson, G. Jungner, Principles and Practice of Screening for Disease, Public Health Papers Number 34 (Geneva, WHO, 1968)

    Google Scholar 

  20. L.D. Maxim, R. Niebo, M.J. Utell, Screening tests: a review with examples. Inhal. Toxicol. 26(13), 811–828 (2014)

    Article  Google Scholar 

  21. A.N. Desai, P. Patel, Stopping the spread of COVID-19. JAMA 323, 1516 (2020)

    Article  Google Scholar 

  22. B. Nussbaumer-Streit, V. Mayr, A.I. Dobrescu, A. Chapman, E. Persad, Quarantine alone or in combination with other public health measures to control COVID-19: A rapid review. Cochrane Database Syst. Rev. 4(4), CD013574 (2020)

    Google Scholar 

  23. S.H.S. Tali, J.J. LeBlanc, Z. Sadiq, O.D. Oyewunmi, C. Camargo, B. Nikpour, N. Armanfard, S.M. Sagan, S. Jahanshahi-Anbuhi, Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin. Microbiol. Rev. 34(3), e00228-20 (2021)

    Article  Google Scholar 

  24. R.S. Burnham, R.S. McKinley, D.D. Vincent, Three types of skin-surface thermometers: a comparison of reliability, validity, and responsiveness. Am. J. Phys. Med. Rehabil. 85(7), 553–558 (2006)

    Article  Google Scholar 

  25. G.B. Dell’Isola, E. Cosentini, L. Canale, G. Ficco, M. Dell’Isola, Noncontact body temperature measurement: uncertainty evaluation and screening decision rule to prevent the spread of COVID-19. Sensors 21, 346 (2021)

    Article  Google Scholar 

  26. P. Ghassemi, T. Joshua Pfefer, J.P. Casamento, R. Simpson, Q. Wang, Best practices for standardized performance testing of infrared thermographs intended for fever screening. PLOS ONE 13, e0203302 (2018)

    Article  Google Scholar 

  27. R. Wölfel, V.M. Corman, W. Guggemos, M. Seilmaier, S. Zange, M.A. Müller, D. Niemeyer, T.C. Jones, P. Vollmar, C. Rothe, M. Hoelscher, T. Bleicker, S. Brünink, J. Schneider, R. Ehmann, K. Zwirglmaier, C. Drosten, C. Wendtner, Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465–469 (2020)

    Article  Google Scholar 

  28. B.D. Kevadiya, J. Machhi, J. Herskovitz, M.D. Oleynikov, W.R. Blomberg, N. Bajwa, D. Soni, S. Das, M. Hasan, M. Patel, A.M. Senan, S. Gorantla, J.E. McMillan, B. Edagwa, R. Eisenberg, C.B. Gurumurthy, S.P.M. Reid, C. Punyadeera, L. Chang, H.E. Gendelman, Diagnostics for SARS-CoV-2 infections. Nat. Mater. 20, 593–605 (2021)

    Article  Google Scholar 

  29. W. Joost Wiersinga, A. Rhodes, A.C. Cheng, S.J. Peacock, H.C. Prescott, Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 324(8), 782–793 (2020)

    Article  Google Scholar 

  30. K.C. Coffey, D.J. Diekema, D.J. Morgan, Interpreting SARS-CoV-2 test results. JAMA 326(15), 1528–1529 (2021)

    Article  Google Scholar 

  31. B. Udugama, P. Kadhiresan, H.N. Kozlowski, A. Malekjahani, M. Osborne, V.Y.C. Li, H. Chen, S. Mubareka, J.B. Gubbay, W.C.W. Chan, Diagnosing COVID-19: the disease and tools for detection. ACS Nano 14(4), 3822–3835 (2020)

    Article  Google Scholar 

  32. L.E. Brümmer, S. Katzenschlager, M. Gaeddert, C. Erdmann, S. Schmitz, M. Bota, M. Grilli, J. Larmann, M.A. Weigand, N.R. Pollock, A. Macé, S. Carmona, S. Ongarello, J.A. Sacks, C.M. Denkinger, Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis. PLOS Med. 18(10), e1003825 (2021)

    Article  Google Scholar 

  33. A.E. Fiore, C.B. Bridges, N.J. Cox, “Seasonal influenza vaccines”. Vaccines for pandemic influenza. Curr. Top. Microbiol. Immunol. 333, 43–82 (2009)

    Google Scholar 

  34. K.M. Edwards, W.A. Orenstein, COVID-19: Vaccines (UpToDate – Literature Review Current Through, 2022)

    Google Scholar 

  35. F. Krammer, SARS-CoV-2 vaccines in development. Nature 586, 516 (2020)

    Article  Google Scholar 

  36. B.S. Graham, Rapid COVID-19 vaccine development. Science 368, 945 (2020)

    Article  Google Scholar 

  37. M.K. Andrew, J.E. McElhaney, Age and frailty in COVID-19 vaccine development. Lancet 396(10267), 1942–1944 (2020)

    Article  Google Scholar 

  38. G. Dagotto, J. Yu, D.H. Barouch, Approaches and challenges in SARS-CoV-2 vaccine development. Cell Host Microbe 28(3), 364–370 (2020)

    Article  Google Scholar 

  39. S. Jain, H. Batra, P. Yadav, S. Chand, COVID-19 vaccines currently under preclinical and clinical studies, and associated antiviral immune response. Vaccine 8(4), 649 (2020)

    Article  Google Scholar 

  40. N. Pardi, M.J. Hogan, F.W. Porter, D. Weissman, mRNA vaccines—a new era in vaccinology. Nat. Rev. Drug Discov. 17(4), 261–279 (2018)

    Article  Google Scholar 

  41. J. Abbasi, COVID-19 and mRNA vaccines—first large test for a new approach. JAMA 324(12), 1125–1127 (2020)

    Article  Google Scholar 

  42. B. Pulendran, P.S. Arunachalam, D.T. O’Hagan, Emerging concepts in the science of vaccine adjuvants. Nat. Rev. Drug Discov. 20, 454–475 (2021)

    Article  Google Scholar 

  43. S.P. Kaur, V. Gupta, COVID-19 vaccine: a comprehensive status report. Virus Res. 288, 198114 (2020)

    Article  Google Scholar 

  44. V. Bajaj, N. Gadi, A.P. Spihlman, S.C. Wu, C.H. Choi, V.R. Moulton, Aging, immunity, and COVID-19: How age influences the host immune response to coronavirus infections? Front. Physiol. (2021). https://doi.org/10.3389/fphys.2020.571416

  45. T. Ura, K. Okuda, M. Shimada, Developments in viral vector-based vaccines. Vaccines (Basel) 2(3), 624–641 (2014)

    Article  Google Scholar 

  46. Y. Lazebnik, Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects. Oncotarget 12(25), 2476–2488 (2021)

    Article  Google Scholar 

  47. Z. Matić, M. Šantak, Current view on novel vaccine technologies to combat human infectious diseases. Appl. Microbiol. Biotechnol. 106, 25–56 (2022)

    Article  Google Scholar 

  48. A. Jara, E.A. Undurraga, C. González, F. Paredes, T. Fontecilla, G. Jara, A. Pizarro, J. Acevedo, K. Leo, F. Leon, C. Sans, P. Leighton, P. Suárez, H. García-Escorza, R. Araos, Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N. Engl. J. Med. 385, 875 (2021)

    Article  Google Scholar 

  49. N. Al Kaabi, Y. Zhang, S. Xia, Y. Yang, M.M. Al Qahtani, N. Abdulrazzaq, M. Al Nusair, M. Hassany, J.S. Jawad, J. Abdalla, S.E. Hussein, S.K. Al Mazrouei, M. Al Karam, X. Li, X. Yang, W. Wang, B. Lai, W. Chen, S. Huang, Q. Wang, T. Yang, Y. Liu, R. Ma, Z.M. Hussain, T. Khan, M.S. Fasihuddin, W. You, Z. Xie, Y. Zhao, Z. Jiang, G. Zhao, Y. Zhang, S. Mahmoud, I. ElTantawy, P. Xiao, A. Koshy, W.A. Zaher, H. Wang, K. Duan, A. Pan, X. Yang, Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. JAMA 326, 35 (2021)

    Article  Google Scholar 

  50. S.L. Xia, Y.T. Zhang, Y.X. Wang, H. Wang, Y.K. Yang, G.F. Gao, W.J. Tan, G.Z. Wu, M. Xu, Z.Y. Lou, W.J. Huang, W.B. Xu, B.Y. Huang, W. Wang, W. Zhang, N. Li, Z.Q. Xie, X. Zhu, L. Ding, W.Y. You, Y.X. Zhao, J. Zhao, L.L. Huang, X.Z. Shi, Y.L. Yang, G.X. Xu, W.L. Wang, P.P. Liu, M. Ma, Y.L. Qiao, S.H. Zhao, J.J. Chai, Q.Q. Li, F. Hui, Y. Xu, X.T. Zheng, W.S. Guo, X.M. Yang, Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial. Lancet Infect. Dis. 22(2), 196–208 (2022)

    Article  Google Scholar 

  51. M. Sadarangani, A. Marchant, T.R. Kollmann, Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat. Rev. Immunol. 21, 475–484 (2021)

    Article  Google Scholar 

  52. M.T. Mascellino, F. Di Timoteo, M. De Angelis, A. Oliva, Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety. Infect. Drug Resist. 14, 3459–3476 (2021)

    Article  Google Scholar 

  53. H.F. Florindo, R. Kleiner, D. Vaskovich-Koubi, R.C. Acúrcio, B. Carreira, E. Yeini, G. Tiram, Y. Liubomirski, R. Satchi-Fainaro, Immune-mediated approaches against COVID-19. Nat. Nanotechnol. 15, 630–645 (2020)

    Article  Google Scholar 

  54. E.N. Perencevich, D.J. Diekema, M.B. Edmond, Moving personal protective equipment into the community: face shields and containment of COVID-19. JAMA 323(22), 2252–2253 (2020)

    Article  Google Scholar 

  55. L. Martinelli, V. Kopilaš, M. Vidmar, C. Heavin, H. Machado, Z. Todorović, N. Buzas, M. Pot, B. Prainsack, S. Gajović, Face masks during the COVID-19 pandemic: a simple protection tool with many meanings. Front. Public Health 8, 606635 (2021)

    Article  Google Scholar 

  56. T. Hasan, J. Beardsley, B.J. Marais, T.A. Nguyen, G.J. Fox, The implementation of mass-vaccination against SARS-CoV-2: a systematic review of existing strategies and guidelines. Vaccines (Basel) 9, 326 (2021)

    Article  Google Scholar 

  57. E.J. Haas, F.J. Angulo, J.M. McLaughlin, E. Anis, S.R. Singer, F. Khan, N. Brooks, M. Smaja, G. Mircus, K. Pan, J. Southern, D.L. Swerdlow, L. Jodar, Y. Levy, S. Alroy-Preis, Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 397, 1819–1819 (2021)

    Article  Google Scholar 

  58. A. Singanayagam, S. Hakki, J. Dunning, K.J. Madon, M.A. Crone, A. Koycheva, N. Derqui-Fernandez, J.L. Barnett, M.G. Whitfield, R. Varro, A. Charlett, R. Kundu, J. Fenn, J. Cutajar, V. Quinn, E. Conibear, P.W. Barclay, P.S. Freemont, G.P. Taylor, S. Ahmad, M. Zambon, N.M. Ferguson, P.A. Lalvani, Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet 22(2), 183–195 (2022)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. JIS College of Engineering, Kalyani, West Bengal, India

    Sandip Bag & Swati Sikdar

Authors
  1. Sandip Bag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Swati Sikdar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of CSE, Vel Tech Rangarajan Dr Sagunthala R&D Institute of Science and Technology, Chennai, India

    G. R. Kanagachidambaresan

  2. Department of Biomedical Engineering, North Eastern Hill University, Shillong, Meghalaya, India

    Dinesh Bhatia

  3. Computer Science and Engineering, Vel Tech Rangarajan Dr. Sagunthala R&D, Institute of Science and Technology, Chennai, TN, India

    Dhilip Kumar

  4. North Eastern Indira Gandhi Regional Institute, Shillong, India

    Animesh Mishra

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bag, S., Sikdar, S. (2023). Effective Health Screening and Prompt Vaccination to Counter the Spread of COVID-19 and Minimize Its Adverse Effects. In: Kanagachidambaresan, G.R., Bhatia, D., Kumar, D., Mishra, A. (eds) System Design for Epidemics Using Machine Learning and Deep Learning. Signals and Communication Technology. Springer, Cham. https://doi.org/10.1007/978-3-031-19752-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-19752-9_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-19751-2

  • Online ISBN: 978-3-031-19752-9

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics

Search

Navigation